LON:POLX Polarean Imaging (POLX) Share Price, News & Analysis → Write this ticker symbol down… (From StocksToTrade) (Ad) Free POLX Stock Alerts GBX 1.20 -0.03 (-2.52%) (As of 04:02 PM ET) Add Compare Share Share Today's Range 1.17▼ 1.2150-Day Range 1.23▼ 4.6052-Week Range 1▼ 33Volume3.70 million shsAverage Volume2.57 million shsMarket Capitalization£2.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Polarean Imaging alerts: Email Address Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution About Polarean Imaging Stock (LON:POLX)Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polarizer devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.Read More POLX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart POLX Stock News HeadlinesMay 22, 2024 | americanbankingnews.comPolarean Imaging (LON:POLX) Shares Down 69.2% January 9, 2024 | finance.yahoo.comPolarean Imaging (LON:POLX) Will Have To Spend Its Cash WiselyDecember 21, 2023 | finance.yahoo.comPolarean Imaging "very excited" to announce brand new customer for XENOVIEW polariserOctober 23, 2023 | uk.investing.comPOLX Historical DataSeptember 27, 2023 | proactiveinvestors.comPolarean Imaging appoints new non-executive directorAugust 29, 2023 | finance.yahoo.comCMS grants reimbursement code for the Polarean XENOVIEW™ MRI TechnologyJuly 10, 2023 | finance.yahoo.comWe're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn RateJune 22, 2023 | bizjournals.comDurham medtech names new CEO to steer commercial launchJune 21, 2023 | finanznachrichten.dePolarean Imaging plc: Appointment of Dr. Christopher von Jako as new CEOMay 29, 2023 | finance.yahoo.comRecent 10% pullback isn't enough to hurt long-term Polarean Imaging (LON:POLX) shareholders, they're still up 59% over 5 yearsMay 26, 2023 | proactiveinvestors.comPolarean Imaging focused on gaining commercial traction for XENOVIEWMay 19, 2023 | msn.comThis penny stock has halved in 2023 to 28p! Should I buy?May 12, 2023 | marketwatch.comFirst clinical scan using XENOVIEW conducted at Cincinnati Children's Hospital Medical CenterMay 11, 2023 | finance.yahoo.comFirst clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical CenterApril 17, 2023 | proactiveinvestors.comPolarean Imaging hires consultant to support commercial planningMarch 14, 2023 | proactiveinvestors.comPolarean Imaging gains access to funds after new bridge bank is formed; share suspension liftedMarch 13, 2023 | finance.yahoo.comU.K. tech, life sciences firms outline exposure to failed SVBFebruary 13, 2023 | proactiveinvestors.comPolarean Imaging looking to gain commercial traction for its XENOVIEWDecember 28, 2022 | proactiveinvestors.comPolarean Imaging PLC surges as XENOVIEW gets FDA green lightDecember 28, 2022 | proactiveinvestors.comPolarean Imaging surges as XENOVIEW gets FDA green lightNovember 29, 2022 | finance.yahoo.comPolarean Imaging plc (LON:POLX) has caught the attention of institutional investors who hold a sizeable 44% stakeOctober 27, 2022 | finance.yahoo.comPolarean Imaging's (LON:POLX) investors will be pleased with their notable 96% return over the last three yearsSeptember 22, 2022 | proactiveinvestors.comPolarean Imaging says US FDA requests additional information from manufacturing partner of its xenon-129 gas blend drugSeptember 6, 2022 | finance.yahoo.comPolarean Imaging plc (POLX.L)August 31, 2022 | marketwatch.comPolarean Imaging 1H Pretax Loss Widened on Greater Expenses, FX LossesSee More Headlines Receive POLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:POLX CUSIPN/A CIKN/A Webwww.polarean.com Phone919 206 7900FaxN/AEmployees28Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-14,340,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-75.33% Return on Assets-40.85% Debt Debt-to-Equity Ratio2.30 Current Ratio5.50 Quick Ratio9.80 Sales & Book Value Annual Sales£1.03 million Price / Sales2.58 Cash FlowGBX 0.25 per share Price / Cash Flow4.93 Book ValueGBX 6 per share Price / Book0.21Miscellaneous Outstanding Shares216,260,000Free FloatN/AMarket Cap£2.66 million OptionableNot Optionable Beta0.69 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Kenneth Paul West (Age 67)Chairman of the Board Comp: $44.55kDr. Bastiaan Driehuys Ph.D. (Age 54)Founder, Chief Scientific Officer & Director Comp: $28.65kMr. Charles Fremont Osborne Jr. (Age 58)CFO & Director Comp: $268.56kDr. Christopher Richard Von Jako Ph.D. (Age 54)CEO & Director Mr. Neil Wadehra (Age 44)Vice President of Operations Mr. Alex Dusek (Age 57)Chief Commercial Officer Mr. Stephen AustinCompany SecretaryMore ExecutivesKey CompetitorsAdvanced OncotherapyLON:AVORUA Life SciencesLON:RUAMyHealthCheckedLON:MHCSurgical Innovations GroupLON:SUNDeltex Medical GroupLON:DEMGView All Competitors POLX Stock Analysis - Frequently Asked Questions How have POLX shares performed in 2024? Polarean Imaging's stock was trading at GBX 6.25 at the beginning of 2024. Since then, POLX stock has decreased by 80.8% and is now trading at GBX 1.20. View the best growth stocks for 2024 here. What other stocks do shareholders of Polarean Imaging own? Based on aggregate information from My MarketBeat watchlists, some companies that other Polarean Imaging investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP). How do I buy shares of Polarean Imaging? Shares of POLX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:POLX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarNext President (Not Trump. Not Biden.)The Freeport SocietyWrite this ticker symbol down…StocksToTradeNvidia’s Quiet $1 Trillion PivotWeiss Ratings4 Cryptos BETTER than BitcoinTrue Market Insiders[Urgent!] Generational Wealth GameplanCrypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThe only AI company to buyPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polarean Imaging plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
